Biochemistry, Genetics and Molecular Biology
Energy Transfer
99%
Protein Interaction
69%
Protein
69%
Kinase
62%
Development
60%
Dimerization
59%
Fluorescence-Lifetime Imaging Microscopy
56%
Cancer Cell
55%
Fluorescence
54%
Screening
50%
Mutant
48%
Epidermal Growth Factor Receptor
48%
Wild Type
48%
Progression Free Survival
46%
Fluorescence Resonance Energy Transfer
46%
Mammalian Target of Rapamycin
46%
Phosphorylation
43%
Cetuximab
38%
Lifespan
36%
Comprehension
35%
Fluorescence Anisotropy
34%
Time
31%
Mutation
29%
Feedback System
27%
Cell Membrane
27%
Tumor Suppressor Protein
27%
Clinical Trial
27%
Internalization
27%
Steady State
27%
Molecule
24%
Immunity
23%
Evolution
23%
Interaction Study
23%
T Cell
23%
in Vivo Gene Transfer
23%
Flow Cytometry
23%
Colon
23%
Substrate Interaction
23%
Tyrosine Kinase Inhibitor
18%
Lapatinib
17%
Nested Gene
16%
Growth
15%
Ubiquitination
15%
CD14
15%
CD33
15%
Monocyte
15%
Protein-Protein Interaction
14%
Probe
14%
STAT5
13%
Ezrin
13%
Medicine and Dentistry
Neoplasm
100%
Therapeutic Procedure
98%
Epidermal Growth Factor Receptor
83%
Patient
68%
Progression Free Survival
49%
Cancer Model
48%
Head and Neck Cancer
46%
Systemic Therapy
46%
Mammalian Target of Rapamycin Inhibitor
46%
Prostate Cancer
46%
Clinical Trial
38%
Protein
37%
Analysis
34%
Cetuximab
30%
Combination Therapy
30%
Basal Like Breast Cancer
26%
Exosome
24%
Cells
24%
Monitoring
23%
Lung Adenocarcinoma
23%
Evolution
23%
Phosphotransferase
23%
Recurrent Disease
23%
Immunosuppressive Treatment
23%
Fluorine-18
23%
Gamma Urogastrone
23%
Triple Negative Breast Cancer
23%
Protein Interaction
23%
Cancer Therapy
23%
Heterodimer
23%
Epidermal Growth Factor Receptor 3
23%
Toxicity
23%
Phosphoinositide 3-Kinase
23%
Radiation Biology
23%
Programmed Death-Ligand 1
23%
Mutant
21%
Chemotherapeutic Agent
21%
Drug
21%
Tissues
20%
Breast Cancer
20%
Cancer Research
19%
Targeted Therapy
19%
Receptor
18%
Cancer Cell
17%
Non Small Cell Lung Cancer
15%
Macrophage
15%
Biological Marker
15%
Monocyte
15%
Colorectal Cancer
14%
Prognosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
74%
Neoplasm
68%
Phosphotransferase
57%
Cetuximab
51%
Progression Free Survival
49%
Head and Neck Cancer
46%
Prostate Cancer
46%
Cancer Model
46%
Mammalian Target of Rapamycin Inhibitor
46%
Chemotherapy
35%
Protein Tyrosine Kinase Inhibitor
35%
Dimer
34%
Breast Cancer
34%
Colon Cancer
30%
Heterodimer
30%
Epidermal Growth Factor Receptor
30%
Colorectal Cancer
29%
Protein
28%
Drug
27%
Metastasis
25%
Peptide
24%
Clinical Trial
23%
Drug Delivery
23%
Toxicity
23%
Biodistribution
23%
Liposome
23%
Nanoparticle
23%
Combination Therapy
23%
Lung Adenocarcinoma
23%
Competitive Inhibitor
23%
Lapatinib
17%
Non Small Cell Lung Cancer
16%
Microscopy
15%
Overall Survival
14%
Prognosis
14%
Ezrin
13%
Melanoma
11%
Head and Neck Squamous Cell Carcinoma
11%
Squamous Cell Carcinoma
11%
Adenosine Triphosphate
11%
Neu Differentiation Factor
11%
Mouse
11%
Lung Cancer
9%
Actin
9%
Tumor Growth
8%
Platinum
7%
Biological Marker
7%
Protein Tyrosine Kinase
7%
Lipid
7%
Elimination
7%